CWP
ORGO icon

CFM Wealth Partners’s Organogenesis Holdings ORGO Stock Holding History

CFM Wealth Partners’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,700
Closed -$6K – 371
2020
Q2 		$6K Hold
1,700
– – ﹤0.01% 427
2020
Q1 		$5K Hold
1,700
– – ﹤0.01% 475
2019
Q4 		$9K Buy
+1,700
New +$10.8K ﹤0.01% 432

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

CFM Wealth Partners's ORGO Position: Q3 2020 in Review

CFM Wealth Partners sold out of Organogenesis Holdings (ORGO) in Q3 2020, closing a stake of 1,700 shares — an estimated $6K sold.

CFM Wealth Partners first reported a position in ORGO in Q4 2019 and held it in 3 quarters. The position peaked at $9K in Q4 2019. 50 funds tracked by Wall St. Rank hold ORGO as of Q3 2020.

  • CFM Wealth Partners reported no remaining Organogenesis Holdings position as of Q3 2020 after selling out during the quarter.
  • CFM Wealth Partners sold 1,700 Organogenesis Holdings shares in Q3 2020, an estimated $6K.
  • CFM Wealth Partners first reported a position in Organogenesis Holdings in Q4 2019 and held it in 3 quarters.
  • CFM Wealth Partners's Organogenesis Holdings position peaked at $9K in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2020.

Based on CFM Wealth Partners's 13F filing for Q3 2020, filed 10 Nov 2020.